Benzodiazepines and Z-Drugs During Lactation

  • Faruk Uguz


Lactating women may experience psychiatric disturbances such as depression, anxiety, and insomnia, which require benzodiazepines or Z-drugs for treatment. The most important aspect of treatment during the lactation period is to achieve balance between improvement of maternal psychiatric symptoms and safety of breastfed infants. If the decision to administer a benzodiazepine is made, lorazepam appears to be the most preferable agent with respect to the safety of infants. Limited available data suggest that zaleplon, zopiclone, and zolpidem may be compatible with breastfeeding. These medications should be used at as low doses as possible and for a short time. Moreover, the infants exposed to these drugs via breast milk should be carefully monitored.


Benzodiazepine Z-drugs Breastfeeding Lactation 


  1. 1.
    Goodman JH, Watson GR, Stubbs B. Anxiety disorders in postpartum women: a systematic review and meta-analysis. J Affect Disord. 2016;203:292–331.CrossRefGoogle Scholar
  2. 2.
    Ko HS, Shin J, Kim MY, Kim YH, Lee J, Kil KC, Moon HB, Lee G, Sa-Jin K, Kim BI. Sleep disturbances in Korean pregnant and postpartum women. J Psychosom Obstet Gynecol. 2012;33:85–90.CrossRefGoogle Scholar
  3. 3.
    Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, Khawaja IS, Diem S, Koffel E, Quelette J, Butler M, Kane RL. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by American College of Physicians. Ann Intern Med. 2016;165:103–12.CrossRefGoogle Scholar
  4. 4.
    Kronenfeld N, Berlin M, Shaniv D, Berkovitch M. Use of psychotropic medications in breastfeeding women. Birth Defects Res. 2017;109:957–97.CrossRefGoogle Scholar
  5. 5.
    Oddy WH. Long-term health outcomes and mechanisms associated with breastfeeding. Expert Rev Pharmacoeconomics Outcomes Res. 2002;2:161–77.CrossRefGoogle Scholar
  6. 6.
    Uguz F, Sharma V. Mood stabilizers during breastfeeding: a systematic review of the recent literature. Bipolar Disord. 2016;18:325–33.CrossRefGoogle Scholar
  7. 7.
    Kanhere S. Recent advances in neonatal seizures. Indian J Pediatr. 2014;81:917–25.CrossRefGoogle Scholar
  8. 8.
    Offringa M, Newton R, Cozijnsen MA, Nevitt SJ. Prophylactic drug management for febrile seizures in children. Cochrane Database Syst Rev. 2017;2:CD003031.PubMedGoogle Scholar
  9. 9.
    Wu W, Zhang L, Xue R. Lorazepam or diazepam for convulsive status epilepticus: a meta-analysis. J Clin Neurosci. 2016;29:133–8.CrossRefGoogle Scholar
  10. 10.
    Davanzo R, Bo SD, Copertino M, Zanelli E, Matarazzo L. Antiepileptic drugs and breastfeeding. Ital J Pediatr. 2013;39:50.CrossRefGoogle Scholar
  11. 11.
    Orsolini L, Valchera A, Bellantuono C. Antidepressants and anxiolytics during lactation. In: Uguz F, editor. Psychiatric disorders during the postpartum period in light of current advances. New York, NY: Nova Science Publishers, Inc.; 2016. p. 115–42.Google Scholar
  12. 12.
    Kelly LE, Poon S, Madadi P, Koren G. Neonatal benzodiazepines exposure during breastfeeding. J Pediatr. 2012;161:448–51.CrossRefGoogle Scholar
  13. 13.
    Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv. 2002;53:39–49.CrossRefGoogle Scholar
  14. 14.
    Rubin ET, Lee A, Ito S. When breastfeeding mothers need CNS-acting drugs. Can J Clin Pharmacol. 2004;11:e257–66.PubMedGoogle Scholar
  15. 15.
    Borgatta L, Jenny RW, Gruss L, Ong C, Barad D. Clinical significance of methohexital, meperidine, and diazepam in breast milk. Clin Pharmacol. 1997;37:186–92.CrossRefGoogle Scholar
  16. 16.
    Birnbaum CS, Cohen LS, Bailey JW, Grush LR, Robertson LM, Stowe ZN. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series. Pediatrics. 1999;104:e11.CrossRefGoogle Scholar
  17. 17.
    Soussan C, Gouraud A, Portolan G, Jean-Pastor MJ, Pecriaux C, Montastruc JL, Damase-Michel C, Lacroix I. Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database. Eur J Clin Pharmacol. 2014;70:1361–6.CrossRefGoogle Scholar
  18. 18.
    Uguz F. Breastfeeding and psychotropic medications. In: Uguz F, editor. Psychotropic drugs and medical conditions. New York, NY: Nova Science Publishers Inc.; 2017. p. 209–29.Google Scholar
  19. 19.
    Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ. Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk. Br J Clin Pharmacol. 1995;40:231–6.CrossRefGoogle Scholar
  20. 20.
    Nitsun M, Szokol JW, Saleh J, Murphy GS, Vender JS, Luong L, Raikoff K, Avram MJ. Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk. Clin Pharmacol Ther. 2006;79:549–57.CrossRefGoogle Scholar
  21. 21.
    Okun ML, Ebert R, Saini B. A review of sleep-promoting medications used in pregnancy. Am J Obstet Gynecol. 2015;212:428–41.CrossRefGoogle Scholar
  22. 22.
    Darwish M, Martin PT, Cevallos WH, Tse S, Wheeler S, Troy SM. Rapid disappearance of zaleplon from breast milk after oral administration to lactating women. J Clin Pharmacol. 1999;39:670–4.CrossRefGoogle Scholar
  23. 23.
    Pons G, Francoual C, Guillet P, Moran C, Hermann P, Bianchetti G, Thiercelin JF, Thenot JP, Olive G. Zolpidem excretion in breast milk. Eur J Clin Pharmacol. 1989;37:245–8.CrossRefGoogle Scholar
  24. 24.
    Matheson I, Sande HA, Gaillot J. The excretion of zopiclone into breast milk. Br J Clin Pharmacol. 1990;30:267–71.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Faruk Uguz
    • 1
  1. 1.Department of Psychiatry, Meram Faculty of MedicineNecmettin Erbakan UniversityKonyaTurkey

Personalised recommendations